Pharmafile Logo
Pharmafocus logo
Advanced Search

Ashfield launches Global Impact On Society Initiative

August 16, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ashfield, part of UDG Healthcare plc (LON: UDG), a global leader in providing outsourced healthcare services to pharmaceutical, device and …

News
Press release

13 deaths in Aurinia’s lupus drug trial despite hitting Phase II target

August 16, 2016
Manufacturing and Production, Research and Development Aurinia, Phase II, biotech, patient deaths, voclosporin

Canadian biotech Aurinia Pharmaceuticals has announced the topline Phase IIb trial results of its lupus nephritis (LN) treatment voclosporin, which …

News
kalydeco

Vertex stumbles in Phase III cystic fibrosis trials

August 16, 2016
Manufacturing and Production, Research and Development Vertex, cystic fibrosis, phase III

Vertex Pharmaceuticals has provided an update on its ongoing Phase III trials investigating VX-661 in combination with Kalydeco (ivacaftor) in …

News
ucb_logo_pole2

US court rules in favour of UCB in patent dispute, shares jump

August 16, 2016
Manufacturing and Production, Research and Development, Sales and Marketing UCB, lacosamide, patent, vimpat

UCB has received a major boost after a Delaware district court confirmed the validity of the company’s patents on one …

News

FDA finds drug class at centre of French trial tragedy do not pose similar safety risks

August 15, 2016
Manufacturing and Production, Research and Development Bial, Biotrial, FDA, faah, rennes

The US Food and Drug Administration (FDA) has issued a statement following the results of their investigation into the recent …

News
eu_flag

UK Government commits to funding EU research projects after Brexit

August 15, 2016
Manufacturing and Production, Research and Development brexit, research

Chancellor Phillip Hammond has outlined a government commitment to guarantee EU funding for British research projects made before Britain leaves …

News
top_ten

Top ten stories in the pharmaceutical industry this week

August 15, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest stories, pharma, pharmafile, stories of the week, top 10

It’s Monday and we’re just getting back to it after a busy week in pharma. Unfortunately, it was mostly bad …

News
shutterstock_76507048

Acute coronary syndrome market to grow to over $12 billion by 2022

August 15, 2016
Research and Development, Sales and Marketing GlobalData, acute coronary syndrome

The acute coronary syndrome (ACS) market is forecast to rise from $7.8 billion in 2015 to $12.1 billion by 2022 …

News
doc_writing

Endo to withdraw FDA application for abuse-deterrent labelling on opioid drug

August 15, 2016
Sales and Marketing Endo, Endo International, abuse deterrent, opioid

Endo International has announced that, following discussions with the US Food and Drug Administration (FDA), it has decided to withdraw …

News
novartis_side_building

Novartis invests €100 million to expand French manufacturing plant

August 15, 2016
Manufacturing and Production, Sales and Marketing Novartis, manufacturing

Novartis has sealed the deal with construction firm Jacobs Engineering group to expand production operations at its France Center of …

News
vaccination

Sanofi launches dengue immunisation program in Brazil

August 15, 2016
Research and Development, Sales and Marketing Brazil, Sanofi, Sanofi Pasteur, Vaccine, dengue, immunisation, vaccines

Sanofi has announced that it has initiated the first dengue immunisation public program in the Americas, with 500,000 individuals set …

News
abbvie_0

Study shows promise for Venclexta in acute myelogenous leukaemia

August 12, 2016
Research and Development, Sales and Marketing AbbVie, Genentech, Roche, Venclexta, venetoclax

A study published in Cancer Discovery, the journal of the American Association for Cancer Research, suggests that Vencletxa (venetoclax) is …

News
clinical_trial-web

Promising results for new type 2 diabetes management procedure

August 12, 2016
Research and Development, Sales and Marketing Fractyl, Revita, diabetes, type 2 diabetes

Fractyl Laboratories has revealed data from its first-in-human study of Revita duodenal mucosal resurfacing (Revita DMR), a new 60-minute, non-surgical …

News

Ashfield publishes a guide to Patient Support Programmes: Ten steps to success

August 12, 2016
Medical Communications, Research and Development, Sales and Marketing

The priorities of Pharma and healthcare organisations are better aligned as a result of the industry’s increased efforts to put …

News
Press release
cdc1

Number of babies born with opioid dependence has tripled in US, says CDC report

August 12, 2016
Medical Communications, Research and Development CDC, addicted, babies, opioid dependence, opioids

A new report from the Centers for Disease Control and Prevention (CDC) has highlighted a sharp increase in the number …

News
allergan

Allergan set to acquire eye-care biotech ForSight VISION5

August 12, 2016
Medical Communications, Sales and Marketing Allergan, ForSight VISION5, acquisition, biotech, eye care

Allergan has announced its acquisition of privately-held, clinical-stage eye-care biotech ForSight VISION5 for a $95 million upfront payment and a …

News

Novartis admits employees gave kickbacks to doctors in South Korea

August 12, 2016
Medical Communications, Research and Development Novartis, kickbacks, south korea

Novartis has confirmed that six employees in South Korea gave kickbacks to doctors, as the current and former employees face …

News
laboratory-testing-az

Advaxis follows up Amgen deal with Phase IIa cancer trial success

August 12, 2016
Medical Communications, Research and Development Advaxis, immunotherapy. cancer. Amgen

Advaxis, a US biotech in cancer immunotherapy development, has announced that its lead immunotherapy product axalimogene filolisbac (AXAL) has hit …

News
gilead-sciences

Gilead to work with Genmab on HIV targeting technology

August 12, 2016
Medical Communications, Research and Development, Sales and Marketing Genmab, Gilead, HIV, duobody

Genmab has announced that it has entered into a collaboration deal with Gilead Sciences to use the DuoBody technology platform …

News
astrazeneca_building_white

Thousands to benefit with new anti-clotting drug recommendation, says NICE

August 12, 2016
Medical Communications, Sales and Marketing AstraZeneca, Brilique, ticagrelor

The National Institute for Health and Care Excellence (NICE) has published new draft guidance recommending AstraZeneca’s Brilique (ticagrelor) for people …

News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026